Reducing the drug burden of sedative and anticholinergic medications in older adults : a scoping review of explicit decision criteria
Copyright © 2024. Published by Elsevier B.V..
OBJECTIVES: To describe the extent, characteristics, and knowledge gaps regarding explicit decision criteria for deprescribing drugs with anticholinergic or sedative properties (Ach/Sed) in older adults.
DESIGN: Scoping review.
SETTING AND PARTICIPANTS: Original studies, clinical trial protocols, grey literature, and Summaries of Product Characteristics.
METHODS: Searches targeting explicit decision criteria for deprescribing Ach/Sed were performed across MEDLINE, EMBASE, CINAHL, and Web of Science, including trial registries (clinicaltrials.gov, ICTRP, EU-CTR, ANZCTR) for pertinent articles, study protocols. Additionally, to encompass non-traditional or 'grey literature' sources, Google searches and relevant agency websites were explored, alongside the summary of product characteristics for Ach/Sed.
RESULTS: The initial literature search identified 8,192 unique data sources. After review, 188 original articles or books, 79 internet sources, and 127 SmPCs were included. Examining these sources for explicit criteria for 154 Ach/Sed, overall, 1,271 explicit criteria guidance for identifying clinical scenarios warranting deprescription of Ach/Sed across 145/154 Ach/Sed were identified. These criteria were identified mainly from qualitative research and Summaries of Product Characteristics. Additionally, 455 criteria-based recommendations suggesting approaches for tapering implementation across 76/154 Ach/Sed were identified, mostly from sources classified as expert opinions. Significant heterogeneity was found across the approaches for tapering Ach/Sed.
CONCLUSIONS: This scoping review provides a comprehensive overview of the literature providing guidance for clinical scenarios where Ach/Sed should be deprescribed and highlights the existing knowledge gaps regarding comprehensive guidance on tapering these drugs which warranties future research and development.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:121 |
|---|---|
| Enthalten in: |
Archives of gerontology and geriatrics - 121(2024) vom: 28. Apr., Seite 105365 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rodríguez-Ramallo, Hector [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 25.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.archger.2024.105365 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368547787 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368547787 | ||
| 003 | DE-627 | ||
| 005 | 20240425232915.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240217s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.archger.2024.105365 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM368547787 | ||
| 035 | |a (NLM)38364710 | ||
| 035 | |a (PII)S0167-4943(24)00041-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rodríguez-Ramallo, Hector |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reducing the drug burden of sedative and anticholinergic medications in older adults |b a scoping review of explicit decision criteria |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024. Published by Elsevier B.V. | ||
| 520 | |a OBJECTIVES: To describe the extent, characteristics, and knowledge gaps regarding explicit decision criteria for deprescribing drugs with anticholinergic or sedative properties (Ach/Sed) in older adults | ||
| 520 | |a DESIGN: Scoping review | ||
| 520 | |a SETTING AND PARTICIPANTS: Original studies, clinical trial protocols, grey literature, and Summaries of Product Characteristics | ||
| 520 | |a METHODS: Searches targeting explicit decision criteria for deprescribing Ach/Sed were performed across MEDLINE, EMBASE, CINAHL, and Web of Science, including trial registries (clinicaltrials.gov, ICTRP, EU-CTR, ANZCTR) for pertinent articles, study protocols. Additionally, to encompass non-traditional or 'grey literature' sources, Google searches and relevant agency websites were explored, alongside the summary of product characteristics for Ach/Sed | ||
| 520 | |a RESULTS: The initial literature search identified 8,192 unique data sources. After review, 188 original articles or books, 79 internet sources, and 127 SmPCs were included. Examining these sources for explicit criteria for 154 Ach/Sed, overall, 1,271 explicit criteria guidance for identifying clinical scenarios warranting deprescription of Ach/Sed across 145/154 Ach/Sed were identified. These criteria were identified mainly from qualitative research and Summaries of Product Characteristics. Additionally, 455 criteria-based recommendations suggesting approaches for tapering implementation across 76/154 Ach/Sed were identified, mostly from sources classified as expert opinions. Significant heterogeneity was found across the approaches for tapering Ach/Sed | ||
| 520 | |a CONCLUSIONS: This scoping review provides a comprehensive overview of the literature providing guidance for clinical scenarios where Ach/Sed should be deprescribed and highlights the existing knowledge gaps regarding comprehensive guidance on tapering these drugs which warranties future research and development | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Anticholinergic Burden | |
| 650 | 4 | |a Deprescription | |
| 650 | 4 | |a Drugs with Anticholinergic or Sedative Properties | |
| 650 | 4 | |a Older Patients | |
| 650 | 4 | |a Potentially Inappropriate Medication List | |
| 650 | 7 | |a Hypnotics and Sedatives |2 NLM | |
| 650 | 7 | |a Cholinergic Antagonists |2 NLM | |
| 700 | 1 | |a Báez-Gutiérrez, Nerea |e verfasserin |4 aut | |
| 700 | 1 | |a Villalba-Moreno, Ángela |e verfasserin |4 aut | |
| 700 | 1 | |a Jaramillo Ruiz, Didiana |e verfasserin |4 aut | |
| 700 | 1 | |a Santos-Ramos, Bernardo |e verfasserin |4 aut | |
| 700 | 1 | |a Prado-Mel, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez-Fidalgo, Susana |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of gerontology and geriatrics |d 1990 |g 121(2024) vom: 28. Apr., Seite 105365 |w (DE-627)NLM023899212 |x 1872-6976 |7 nnns |
| 773 | 1 | 8 | |g volume:121 |g year:2024 |g day:28 |g month:04 |g pages:105365 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.archger.2024.105365 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 121 |j 2024 |b 28 |c 04 |h 105365 | ||